Corporate Finance

The business and financial acumen of Nelson Hardiman’s Corporate Finance group help our healthcare and life sciences clients succeed in a competitive and evolving market. We have helped drive many next-generation healthcare ideas and initiatives to realization, and provided adept guidance to industry stalwarts, grounded in our firm grasp on corporate finance.

Known for our adept operational and turnaround guidance for hospitals and healthcare systems, we apply the same skillset to handling the corporate finance issues of other healthcare providers, professionals and start-ups. We blend our deep knowledge of corporate finance with a keen understanding of the trends for U.S. healthcare and life sciences companies to meet the financial needs of our clients.

Our Work Includes:

  • Entity Formation Formed over five hundred entities, corporations of all types, LLCs, PLLCs, LPs, trusts, and non-profits, together with governance documents to support regular business operations, financing, and mergers.
  • Factoring Counseled and documented various factoring and ABL lines for medical groups, hedge funds, and lenders.
  • Financings Closed over 50 financings, collateralized, secured, unsecured, including bank rate and oil price hedging obligations, and credit swaps of various kinds, of over $1 million dollars to over $25 billion dollars.
  • HUD Financings Documented financing for $25 million bridge to HUD lending from private lender to health care facility; completed over a dozen HUD 242 and related applications for financing clients.
  • Merger Cases Advised on Clayton Act and Sherman Act merger cases, defended Section 7 cases in US District Court, made HSR and related filings, handled extensive Second Requests, and CIDs.
  • Pharmacy and Laboratory Acquisitions Counseled on over two dozen pharmacy acquisitions and laboratory acquisitions, handling CHOWs and regulatory approvals; counseled on 340B program requirements for structuring cash flows in certain pharmacy acquisitions.
  • Private Placements for Cannabis Markets Recently documented over 40 private placement memoranda, creating complex investment structure into high-risk new markets involving cannabis business.